ArticlePlastic and reconstructive surgery. Global open2025
Gracilis Muscle Flap for Ankle Soft Tissue Reconstruction: A Systematic Review and Meta-analysis of Postoperative Outcomes.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gracilis Muscle Flap for Ankle Soft Tissue Reconstruction: A Systematic Review and Meta-analysis of Postoperative Outcomes.Plastic and reconstructive surgery. Global open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The gracilis muscle flap is valuable as a reconstructive option because of its reliable anatomy and minimal donor-site morbidity. The aim of this systematic review was to evaluate acute perioperative complications and long-term outcomes of the gracilis muscle flap in distal lower limb reconstruction following trauma, infections, or oncological resections. Methods: This review was registered with PROSPERO (CRD42023486475) and adhered to PRISMA guidelines. All primary studies on gracilis flaps for lower leg soft tissue reconstruction were included, excluding those with flap recipient sites above the knee, isolated tendon repair, or nonprimary research articles. Searches were performed across Ovid MEDLINE, Ovid Embase, Cochrane CENTRAL, and PubMed. Results: Fifty-eight articles involving 1232 patients who underwent lower extremity reconstruction with a gracilis flap were included. Indications for surgery were trauma (n = 146), diabetes (n = 116), oncological (n = 31), infection (n = 27), other (n = 2), and heterogeneous (n = 910). A total of 397 (32.2%) complications were reported. In heterogeneous studies, pooled proportions were 0.22 for acute postoperative complications, 0.17 for recipient-site events, and 0.12 for donor-site morbidity, with oncological and infection cases showing the highest complication rates. The most common complications for each category were total flap loss (79, 6.4%), recipient infection (14, 1.1%), and donor-site scarring (14, 1.1%). Conclusions: The gracilis flap is a reliable option for reconstructing a wide array of soft tissue defects of the distal lower extremity, with modifications to increase its coverage area. The long-term functional and aesthetic outcomes after gracilis flap reconstruction are undescribed.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.